1. Abilify. 2003 Bristol-Myers Squibb Company, Princeton, NJ, USA.
2. Antipsychotic-induced weight gain: a review of the literature;Allison;J. Clin. Psychiatry,2001
3. The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis;Caro;J. Clin. Psychiatry,2002
4. Casey, D., L'Italien, G., Waldeck, R., Cislo, P., Carson, W., 2003. Metabolic syndrome comparison between olanzapine, aripiprazole, and placebo. Abstract presented at the American Psychiatric Association 156th Annual Meeting, San Francisco, CA. Available from http://www.psych.org/public_info/libr_publ/abstracts.cfm accessed 12 May 2006.
5. Metabolic issues and cardiovascular disease in patients with psychiatric disorders;Casey;Am. J. Med.,2005